$139B
$18.6 Billion
0.14% of portfolio
151,300
Q2 2025
Reduced 40.85%
$0
$19.4 Billion
0.14% of portfolio
162,700
Q2 2025
Reduced 38.81%
$8B
$19.1 Billion
0.14% of portfolio
215,300
Q2 2025
New
$61.1B
$17.3 Billion
0.13% of portfolio
214,733
Q2 2025
Reduced 7.04%
$6.4B
$17.7 Billion
0.13% of portfolio
196,290
Q2 2025
Added 588.74%
$1.26B
$18.2 Billion
0.13% of portfolio
649,400
Q2 2025
Added 40.47%
$1.74B
$17.2 Billion
0.13% of portfolio
226,692
Q2 2025
Reduced 35.23%
$76.9B
$17.9 Billion
0.13% of portfolio
364,135
Q2 2025
Reduced 55.7%
$36.2B
$18 Billion
0.13% of portfolio
58,650
Q2 2025
Added 1,189.01%
$147B
$17.2 Billion
0.13% of portfolio
160,000
Q2 2025
New
-
$16.4 Billion
0.12% of portfolio
-
Q3 2024
Reduced 74.07%
$0
$15.9 Billion
0.12% of portfolio
200,000
Q2 2025
New
-
$16.2 Billion
0.12% of portfolio
-
Q2 2025
Added 82.4%
$141B
$15.8 Billion
0.12% of portfolio
227,000
Q2 2025
New
$0
$16.2 Billion
0.12% of portfolio
270,000
Q2 2025
Reduced 52.1%
$22.2B
$16.3 Billion
0.12% of portfolio
91,000
Q1 2025
New
$31.7B
$15.5 Billion
0.11% of portfolio
140,300
Q2 2025
New
$94.6B
$15.5 Billion
0.11% of portfolio
63,016
Q1 2025
New
$70.7B
$14.8 Billion
0.11% of portfolio
38,000
Q2 2025
Reduced 15.56%
$8.13B
$15.2 Billion
0.11% of portfolio
462,800
Q2 2025
New
$61.8B
$15.7 Billion
0.11% of portfolio
70,022
Q1 2025
New
$31B
$15.3 Billion
0.11% of portfolio
175,000
Q4 2024
New
$0
$15.4 Billion
0.11% of portfolio
289,300
Q2 2025
New
-
$15.4 Billion
0.11% of portfolio
-
Q2 2025
New
$86.2B
$14.3 Billion
0.1% of portfolio
49,000
Q2 2025
New
$0
$13.7 Billion
0.1% of portfolio
148,400
Q2 2025
New
$0
$13.8 Billion
0.1% of portfolio
265,600
Q2 2025
Reduced 80.31%
$185B
$13.4 Billion
0.1% of portfolio
157,600
Q2 2025
Reduced 12.44%
$442B
$14.3 Billion
0.1% of portfolio
132,700
Q2 2025
Reduced 63.79%
$0
$13.4 Billion
0.1% of portfolio
163,000
Q2 2025
New
$11.8B
$11.8 Billion
0.09% of portfolio
63,000
Q1 2024
New
$55.9B
$12.2 Billion
0.09% of portfolio
60,550
Q2 2025
New
$0
$10.4 Billion
0.08% of portfolio
204,900
Q2 2025
New
$0
$11.3 Billion
0.08% of portfolio
114,400
Q2 2025
Reduced 11.66%
$0
$10.3 Billion
0.08% of portfolio
91,800
Q2 2025
New
Rigel Pharmaceuticals Inc
-
$11.1 Billion
0.08% of portfolio
-
Q2 2025
Reduced 14.65%
$97B
$9.06 Billion
0.07% of portfolio
29,400
Q2 2025
Reduced 36.5%
$6.68B
$8.96 Billion
0.07% of portfolio
147,600
Q2 2025
New
$4.64B
$9.24 Billion
0.07% of portfolio
292,900
Q2 2025
New
$405B
$9.97 Billion
0.07% of portfolio
27,200
Q2 2025
Added 9.24%
$182B
$9.02 Billion
0.07% of portfolio
17,100
Q4 2024
Reduced 22.62%
$4.73B
$9.12 Billion
0.07% of portfolio
105,300
Q1 2025
New
$2.63B
$9.43 Billion
0.07% of portfolio
544,600
Q2 2025
New
$253M
$9.15 Billion
0.07% of portfolio
902,062
Q2 2025
Reduced 14.71%
$7.8B
$9.03 Billion
0.07% of portfolio
447,000
Q2 2025
New
$1.37B
$9.81 Billion
0.07% of portfolio
242,100
Q2 2025
New
$5.6B
$9.52 Billion
0.07% of portfolio
264,300
Q2 2025
New
$6.77B
$9.51 Billion
0.07% of portfolio
65,500
Q2 2025
New
$0
$10.1 Billion
0.07% of portfolio
257,300
Q2 2025
New
-
$9.25 Billion
0.07% of portfolio
-
Q2 2025
Reduced 49.2%